Kinesiophobia Levels in Patients with Parkinson's Disease: A Case-Control Investigation.

dc.centroFacultad de Ciencias de la Saludes_ES
dc.contributor.authorJiménez-Cebrián, Ana María
dc.contributor.authorBecerro-de-Bengoa-Vallejo, Ricardo
dc.contributor.authorLosa-Iglesias, Marta Elena
dc.contributor.authorDe Labra, Carmen
dc.contributor.authorCalvo-Lobo, César
dc.contributor.authorPalomo-López, Patricia
dc.contributor.authorMartínez-Jiménez, Eva María
dc.contributor.authorNavarro-Flores, Emmanuel María
dc.date.accessioned2025-06-30T06:57:38Z
dc.date.available2025-06-30T06:57:38Z
dc.date.issued2021-04
dc.departamentoEnfermeríaes_ES
dc.description.abstractMultiple sclerosis (MS) is a neurological, chronic, inflammatory, and progressive disease with musculoskeletal problems and neurodegenerative disorders that causes worsening of the health status of patients. The aim of this study was to determine the level of depression in MS patients compared to a population of healthy subjects. The established sample size was 116 subjects matched with the same age, sex, and body mass index. The subjects were recruited from different multiple sclerosis associations and neurology clinics in different public health areas (case group n = 58) and healthy subjects from the same locality (control group n = 58). The scores and categories of the Beck Depression Inventory (BDI) in its Spanish version were collected. There was a clear statistically significant difference (p < 0.05) in the BDI scores between both groups. As a result, we found that the subjects with MS presented worse results with BDI = 9.52 ± 7.70 points compared to the healthy subjects with a BDI score = 5.03 ± 5.14. Within the BDI categories, there were statistically significant differences (p < 0.001), which were greater for the MS group. Depression is a dangerous factor for MS patients, being a trigger for a poorer quality of life.es_ES
dc.identifier.citationRuiz-Sánchez FJ, do Rosário Martins M, Soares S, Romero-Morales C, López-López D, Gómez-Salgado J, Jiménez-Cebrián AM. Impact of Multiple Sclerosis and Its Association with Depression: An Analytical Case-Control Investigation. Healthcare (Basel). 2022 Nov 4;10(11):2218. doi: 10.3390/healthcare10112218. PMID: 36360559; PMCID: PMC9690715.es_ES
dc.identifier.doi10.3390/ijerph18094791
dc.identifier.urihttps://hdl.handle.net/10630/39167
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAttribution 4.0 Internacional*
dc.rights.accessRightsopen accesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectParkinson, Enfermedad dees_ES
dc.subjectEjercicio físico - Aspectos psicológicoses_ES
dc.subject.otherMovement disorderses_ES
dc.subject.otherParkinson's diseasees_ES
dc.subject.otherMusculoskeletal and neural physiological phenomenaes_ES
dc.titleKinesiophobia Levels in Patients with Parkinson's Disease: A Case-Control Investigation.es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationf861977e-2b86-4252-a52b-d8592bcdac2a
relation.isAuthorOfPublication.latestForDiscoveryf861977e-2b86-4252-a52b-d8592bcdac2a

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Kinesiofobia PK...ijerph-18-04791(3).pdf
Size:
313.44 KB
Format:
Adobe Portable Document Format
Description:

Collections